Subject to the Ownership Limitation (defined below), the Reporting Persons may be deemed to beneficially own a total of 2,723,811 shares of Common Stock, consisting of (i) 1,270,153 shares of Common Stock (“Common Shares”) held by Gemini, (ii) 418,556 shares of Common Stock (“Make-Whole Dividend Shares”) issued or being issued to Gemini on or about December 28, 2015, (iii) 979,547 shares of Common Stock issuable upon conversion of 194.44 shares of the Issuer’s Series E 12% Convertible Preferred Stock (“Preferred Shares”) issued to Gemini on or about July 9, 2015 (without dividend accrual), and (iv) 55,556 shares of Common Stock issuable to Gemini upon exercise in full of a Warrant issued to Gemini in connection with the issuance of the Preferred Shares (the “Warrant”).
Could someone please translate this?
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links